AUCrefTmax [Regulatives / Guidelines]

posted by raghup – India, 2021-05-28 12:44 (59 d 13:29 ago) – Posting: # 22376
Views: 486

For an NSAID immediate release Soft gelatin capsules with two way crossover study although if AUCt and Cmax are with in acceptance limits and there is no difference in median Tmax of both Test and Reference, but for AUCrefTmax 90% CI is not within 80-125% (will Health Canada accept the BE study). No outliers detected in the study.

Edit: Please follow the Forum’s Policy[Helmut]

Complete thread:

 Admin contact
21,589 posts in 4,512 threads, 1,530 registered users;
online 5 (0 registered, 5 guests [including 2 identified bots]).
Forum time: Tuesday 02:14 CEST (Europe/Vienna)

The great tragedy of Science – the slaying
of a beautiful hypothesis by an ugly fact.    Thomas Henry Huxley

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz